The lack of β-adrenoceptors results in enhanced insulin sensitivity in mice exhibiting increased adiposity and glucose intolerance

Diabetes

Volumn 54, Issue 12, 2005, Pages 3490-3495

  Asensio, Cédric ^a,b   Jimenez, Maria ^a   Kühne, Françoise ^a   Rohner Jeanrenaud, Françoise ^a   Muzzin, Patrick ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; HOMEOSTASIS; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIVER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; EATING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; HOMEOSTASIS; INSULIN; KINETICS; MICE; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ADRENERGIC, BETA; WEIGHT GAIN;

EID: 33644701421     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.54.12.3490     Document Type: Article

References (31)

1. Arinze IJ, Kawai Y: Adrenergic regulation of glycogenolysis in isolated guinea-pig hepatocytes: evidence that beta 2-receptors mediate catecholamine stimulation of glycogenolysis. Arch Biochem Biophys 225:196-202, 1983
2. Lum BK, Lau YS, Buesa R, Lockwood RH, Kuo SH: Studies on the hyperglycemia and hepatic glycogenolysis produced by alpha and beta adrenergic agonists in the cat. Life Sci 26:1195-1202, 1980
3. Rizza RA, Cryer PE, Haymond MW, Gerich JE: Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 65:682-689, 1980
4. Nishimura H, Saltis J, Habberfield AD, Garty NB, Greenberg AS, Cushman SW, Londos C, Simpson IA: Phosphorylation state of the GLUT4 isoform of the glucose transporter in subfractions of the rat adipose cell: effects of insulin, adenosine, and isoproterenol. Proc Natl Acad Sci U S A 88:11500-11504, 1991
5. Yang J, Hodel A, Holman GD: Insulin and isoproterenol have opposing roles in the maintenance of cytosol pH and optimal fusion of GLUT4 vesicles with the plasma membrane. J Biol Chem 277:6559-6566, 2002
6. Sloan IG, Sawh PC, Bihler I: Influence of adrenalin on sugar transport in soleus, a red skeletal muscle. Mol Cell Endocrinol 10:3-12, 1978
7. Abramson EA, Arky RA: Role of β-adrenergic receptors in counterregulation to insulin-induced hypoglycemia. Diabetes 17:141-146, 1968
8. Burcelin R, Uldry M, Foretz M, Perrin C, Dacosta A, Nenniger-Tosato M, Seydoux J, Cotecchia S, Thorens B: Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype. J Biol Chem 279:1108-1115, 2004
9. Bachman ES, Dhillon H, Zhang CY, Cinti S, Bianco AC, Kobilka BK, Lowell BB: betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 297:843-845, 2002
10. Jimenez M, Leger B, Canola K, Lehr L, Arboit P, Seydoux J, Russell AP, Giacobino JP, Muzzin P, Preitner F: Beta(1)/beta(2)/beta(3)-adrenoceptor knockout mice are obese and cold-sensitive but have normal lipolytic responses to fasting. FEBS Lett 530:37-40, 2002
11. Chan TM, Exton JH: A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem 71:96-105, 1976
12. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
13. Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B: Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37:1202-1208, 1994
14. Barthel A, Schmoll D: Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 285:E685-E692, 2003
15. Perfetti R, Hui H, Chamie K, Binder S, Seibert M, McLenithan J, Silver K, Walston JD: Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol 27:133-144, 2001
16. Grujic D, Susulic VS, Harper ME, Himms-Hagen J, Cunningham BA, Corkey BE, Lowell BB: Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake: a study using transgenic and gene knockout mice. J Biol Chem 272:17686-17693, 1997
17. Hanson RW, Reshef L: Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 66:581-611, 1997
18. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM: Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-138, 2001
19. Young JB, Landsberg L: Suppression of sympathetic nervous system during fasting. Science 196:1473-1475, 1977
20. Leibel RL, Berry EM, Hirsch J: Metabolic and hemodynamic responses to endogenous and exogenous catecholamines in formerly obese subjects. Am J Physiol 260:R785-R791, 1991
21. Arrone LJ, Mackintosh R, Rosenbaum M, Leibel RL, Hirsch J: Cardiac autonomic nervous system activity in obese and never-obese young men. Obes Res 5:354-359, 1997
22. Han XX, Bonen A: Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am J Physiol 274:E700-E707, 1998
23. Bonen A, Megeney LA, McCarthy SC, McDermott JC, Tan MH: Epinephrine administration stimulates GLUT4 translocation but reduces glucose transport in muscle. Biochem Biophys Res Commun 187:685-691, 1992
24. Jones JP, Dohm GL: Regulation of glucose transporter GLUT-4 and hexokinase II gene transcription by insulin and epinephrine. Am J Physiol 273:E682-E687, 1997
25. Laurent D, Petersen KF, Russell RR, Cline GW, Shulman GI: Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans. Am J Physiol 274:E130-E138, 1998
26. Kjekshus J, Gilpin E, Cali G, Blackey AR, Henning H, Ross J Jr: Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J 11:43-50, 1990
27. Tack CJ, Smits P, Willemsen JJ, Lenders JW, Thien T, Lutterman JA: Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes 45:15-22, 1996
28. Lembo G, Napoli R, Capaldo B, Rendina V, Iaccarino G, Volpe M, Trimarco B, Sacca L: Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 90:24-29, 1992
29. Paolisso G, Manzella D, Tagliamonte MR, Rizzo MR, Gambardella A, Varricchio M: Effects of different insulin infusion rates on heart rate variability in lean and obese subjects. Metabolism 48:755-762, 1999
30. Arauz-Pacheco C, Lender D, Snell PG, Huet B, Ramirez LC, Breen L, Mora P, Raskin P: Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects. Am J Hypertens 9:1172-1178, 1996
31. Cruickshank JM: Beta-blockers and diabetes: the bad guys come good. Cardiovasc Drugs Ther 16:457-470, 2002